|
Press Releases |
|
 |
|
Friday, November 25, 2022 |
|
健倍苗苗公佈二零二三財年中期業績 |
健倍苗苗(保健)有限公司 (「健倍苗苗」或「集團」;股份代號:2161.HK) 為香港領先的品牌醫療保健品推廣商及分銷商,集團今天公佈截至二零二二年九月三十日止六個月(「報告期」)的中期業績。 more info >> |
|
JBM Healthcare Announces FY2023 Interim Results |
JBM (Healthcare) Limited ("JBM Healthcare" or the "Group"; Stock Code: 2161), a leading branded healthcare products marketer and distributor in Hong Kong, has announced today the interim results of the Group for the six months ended 30 September 2022 (the "Reporting Period"). more info >> |
|
Wednesday, June 15, 2022 |
|
万隆、雅各臣及健倍苗苗成立合资公司 拓展大中华区及亚洲专科药及品牌医疗保健市场 |
万隆控股集团有限公司(「万隆」,连同其附属公司「万隆集团」; 股份代号:0030.HK),其控股股东为云南白药集团股份有限公司(证券代号000538.SHE) more info >> |
|
萬隆、雅各臣及健倍苗苗成立合資公司 拓展大中華區及亞洲專科藥及品牌醫療保健市場 |
萬隆控股集團有限公司(「萬隆」,連同其附屬公司「萬隆集團」; 股份代號:0030.HK),其控股股東為雲南白藥集團股份有限公司(證券代號000538.SHE) more info >> |
|
Ban Loong, Jacobson & JBM Form Joint Venture to Tap Specialty Drugs and Branded Healthcare Markets in Greater China and Asia |
Ban Loong Holdings Limited ("Ban Loong", together with its subsidiaries, "Ban Loong Group"; stock code: 0030.HK), of which Yunnan Baiyao Group Co., Ltd. (stock code: 000538.SHE) is the controlling shareholder, Jacobson Pharma Corporation Limited ("Jacobson", together with its subsidiaries (excluding JBM Group) more info >> |
|
Tuesday, June 29, 2021 |
|
健倍苗苗(保健)公布二零二一财年全年业绩 |
健倍苗苗(保健)有限公司(「健倍苗苗」或「集团」;股份代号:2161)为香港领先的品牌医疗保健品推广商及分销商,集团今天公布自二零二一年二月五日于香港联合交易所有限公司主板分拆上市后的首份全年业绩。 more info >> |
|
健倍苗苗(保健)公佈二零二一財年全年業績 |
健倍苗苗(保健)有限公司(「健倍苗苗」或「集團」;股份代號:2161)為香港領先的品牌醫療保健品推廣商及分銷商,集團今天公佈自二零二一年二月五日於香港聯合交易所有限公司主板分拆上市後的首份全年業績。 more info >> |
|
JBM Healthcare Announces FY2021 Annual Results |
JBM (Healthcare) Limited ("JBM Healthcare" or the "Group"; Stock Code: 2161), a leading branded healthcare products marketer and distributor in Hong Kong, has announced today the first annual results of the Group after its spin-off listing on the Main Board of The Stock Exchange of Hong Kong Limited on 5 February 2021. more info >> |
|
Friday, February 5, 2021 |
|
健倍苗苗(保健)有限公司于香港联交所主板挂牌上市 |
健倍苗苗(保健)有限公司 (「健倍苗苗」 或「公司」,连同其附属公司统称「集团」),一家总部设于香港的领先品牌医疗保健品推广及分销公司,业务遍及大中华、东南亚及其他选定国家,今天于香港联合交易所有限公司(「香港联交所」)主板正式挂牌买卖,股份代号为2161。 more info >> |
|
健倍苗苗(保健)有限公司於香港聯交所主板掛牌上市 |
健倍苗苗(保健)有限公司 (「健倍苗苗」 或「公司」,連同其附屬公司統稱「集團」),一家總部設於香港的領先品牌醫療保健品推廣及分銷公司,業務遍及大中華、東南亞及其他選定國家,今天於香港聯合交易所有限公司(「香港聯交所」)主板正式掛牌買賣,股份代號為2161。 more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Reach Secures Major Investment to Accelerate Its Global Expansion and Fuel Enterprise Merchant Growth
Feb 20, 2025 23:00 HKT/SGT
|
|
|
GA-ASI 與 CAE 簽署長期協議,共同開發新一代 MQ-9B SkyGuardian(R) 任務訓練器
Feb 20, 2025 22:10 HKT/SGT
|
|
|
HKTDC strengthens local competitiveness and global connections
Feb 20, 2025 22:09 HKT/SGT
|
|
|
Explore Cutting-Edge Cybersecurity Solutions at Exito's 25th Cyber Security Summit
Feb 20, 2025 17:06 HKT/SGT
|
|
|
Prioritise Self-Love and Self-Care This Year For A Better You
Feb 20, 2025 17:00 HKT/SGT
|
|
|
エーザイ、優れた人的資本経営・情報開示に取り組む企業として「人的資本リーダーズ 2024」「人的資本経営品質 ゴールド」に2年連続で選出
Feb 20, 2025 15:00: JST
|
|
|
GA-ASI 与 CAE 签署长期协议,共同开发新一代 MQ-9B SkyGuardian(R) 任务训练器
Feb 20, 2025 14:00 HKT/SGT
|
|
|
KKR、富士ソフトに対する第2回公開買付けを完了
Feb 20, 2025 14:00: JST
|
|
|
Eisai Selected for "Human Capital Leaders 2024" and "Human Capital Management Gold Quality" for Second Consecutive Year, as a Company Committed to Excellent Management and Disclosure of Human Capital Initiatives
Feb 20, 2025 13:29 JST
|
|
|
New HKTDC Chairman appointed
Feb 19, 2025 23:44 HKT/SGT
|
|
|
Champion REIT Announces 2024 Annual Results
Feb 19, 2025 23:08 HKT/SGT
|
|
|
冠君產業信託公佈2024年度全年業績
Feb 19, 2025 22:33 HKT/SGT
|
|
|
冠君产业信托公布2024年度全年业绩
Feb 19, 2025 22:19 HKT/SGT
|
|
|
NEC X & Carbide Ventures Partner To Rapidly Accelerate Early-Stage Startups
Feb 19, 2025 20:16 JST
|
|
|
Mitsubishi Power Advances Bahrain's Industrial Growth with Completion of Alba's Power Station 5 Block 4 Combined Cycle Power Plant Project
Feb 19, 2025 16:54 JST
|
|
|
|
More News >> |
|
|
|
|
|